Background
Substance use, particularly stimulant drugs such as methamphetamine (MA), is associated with increased HIV incidence and disease progression. The mechanism underlying these associations is likely multifactorial, including sexual risk behavior and social networks, but also may be related to drug-induced immune effects. MA triggers both systemic and localized inflammation in a variety of tissues, including the gut mucosa, which is a primary site of HIV transmission and replication. We hypothesized that MA-induced local gut inflammation would increase HIV infectivity in gut tissue thereby increases risk of HIV acquisition.
Methods
To assess MA-induced inflammation in the gut, mucosal mononuclear cells (MMCs) from the gut and/or ex vivo gut explants were co-cultured with MA then cellular phenotype examined via flow cytometry and cytokine production measured by Meso Scale assays. To examine HIV gut tissue susceptibility in the presence/absence of MA, we developed a novel ex vivo gut explant susceptibility assay using infectious dose titration and co-culture with CCR5/CXCR4-expressing T1-GFP indicator cells to quantify both viral replication and transfer. Susceptibility was quantified using a composite area under the curve metric based on time to infection endpoint across viral doses. To test the impact of candidate cytokines (TNF-alpha), we performed gut explant infections in the presence/absence of blocking antibodies.
Results
MA did not significantly affect activation markers on gut MMCs, but did increase TNF-alpha production (p=0.1). Using our ex vivo gut explant susceptibility assay, we found that MA exposure resulted in a modest but significant (p=0.006) increase in gut tissue susceptibility to HIV. We similarly observed increased p24 production with MA exposure in standard gut explant infection (p=0.01), which was blocked in the presence of anti-TNF-alpha antibody but not control IgG (Figure 1).
Conclusions
MA induced higher TNF-alpha production in gut MMCs, and increased ex vivo gut explant susceptibility to productive HIV infection in a TNF-dependent manner. This may suggest a biological mechanism contributing to the increased risk of HIV acquisition among persons who use MA.
Table or Figure
